Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ellume
Biotech
Merck poaches marketing chief from Biogen—Chutes & Ladders
Biogen marketing exec returns to his Merck & Co. roots. PathAI's co-founder charts a new course. And Ellume's U.S. president joins American Gene.
Fraiser Kansteiner
Jun 24, 2022 9:30am
The top 10 Fierce Medtech stories of 2021
Dec 23, 2021 5:00am
Recall of Ellume COVID tests grows to more than 2.2M kits
Nov 12, 2021 9:47am
NIH deals out $77M to develop 12 new rapid COVID tests
Oct 15, 2021 11:23am
Ellume COVID tests recalled over false positive risk
Oct 7, 2021 9:45am
Why at-home rapid COVID tests cost so much
Sep 13, 2021 8:25am
